Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medical Technology Enterprise Consortium is a U.S.-based 501(c)(3) biomedical technology consortium focused on accelerating the development and deployment of medical technologies for military and civilian use. Rather than operating like a traditional therapeutics company with a proprietary drug pipeline, MTEC functions as a public-private innovation and funding platform that connects government agencies, industry, academia, nonprofits, and investors. The organization works under a renewable Other Transaction Agreement with the U.S. Army Medical Research and Development Command and supports programs spanning infectious diseases, trauma, critical care, diagnostics, devices, telehealth, and related medical technologies. MTEC provides funding access, commercialization support, networking, and project management to help members translate technologies toward operational use and market entry. Its website reports hundreds of awarded projects and a large downstream product pipeline across its member ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medical Technology Consortium Enterprise.